Tag: FDA bioequivalence

How Clinician Communication Shapes Patient Trust in Generic Medications

Clinician communication is the most powerful factor in whether patients accept generic medications. Learn how clear, confident explanations about FDA bioequivalence, cost savings, and nocebo effects build trust-and why poor communication leads to non-adherence.

Read More